FDA Inspection 1202396 — Abbott GmbH
The FDA completed an inspection of Abbott GmbH on Jan 17, 2023 in Wiesbaden. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jan 17, 2023
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Wiesbaden (Germany)